Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JAFKX vs. SCHLX: which is better?

Bottom line

JAFKX vs SCHLX: the short answer

JAFKX (Health Sciences Trust) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.

But JAFKX is far broader, holding 173 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.

SCHLX is cheaper at 1.06% vs 1.24% — a difference of $18 a year per $10,000 invested.

Updated Nov 19, 2026

JAFKX vs SCHLX side by side

JAFKXSCHLX
TypeMutual fundMutual fund
Fund familyJohn HancockDWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.24%1.06%
Annual cost per $10k$124$106
10-yr cost on $10k (prospectus)$1,510$1,294
Max front load—0%
12b-1 fee0.25%0%
1-yr return+19.2%—
5-yr return (annualized)+3.9%—
10-yr return (annualized)+8.5%—
Best quarter——
Worst quarter——
Net assets (fund)$251.3M$231.8M
Number of holdings17365
Portfolio turnover68%2%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

15 of JAFKX's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingJAFKXSCHLX
Eli Lilly and Company14.30%13.85%
Johnson and Johnson6.33%6.19%
UnitedHealth Group Incorporated5.95%5.73%
AbbVie Inc.5.28%4.90%
Merck and Co. Inc.4.21%4.85%
Gilead Sciences Inc.2.95%2.78%
Thermo Fisher Scientific Inc.2.67%3.46%
Vertex Pharmaceuticals Incorporated2.38%2.45%
Bristol-Myers Squibb Company2.22%1.50%
Abbott Laboratories2.00%2.39%
Intuitive Surgical Inc.1.98%2.69%
Amgen Inc.1.90%2.88%
Stryker Corporation1.87%2.61%
Danaher Corporation1.51%2.13%
Cardinal Health Inc.1.09%1.34%

Source: SEC Form N-PORT

JAFKX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between JAFKX and SCHLX?
JAFKX (Health Sciences Trust) and SCHLX (DWS Health and Wellness Fund) are both mutual funds. But JAFKX is far broader, holding 173 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
Which is cheaper, JAFKX or SCHLX?
SCHLX has the lower expense ratio (1.06%).
Should I own both JAFKX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.